Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quebec Lung Cancer Screening PLUS Trial - a Randomized Controlled Trial of an Educational Intervention for Untreated Chronic Obstructive Pulmonary Disease (COPD) and/or Cardiovascular Disease (CVD) Identified During Lung Cancer Screening

NCT05444062 is registered in ClinicalTrials.gov with Nicole Ezer, MD, FRCPC, MPH as lead sponsor.

NCT NCT05444062
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05444062 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quebec Lung Cancer Screening PLUS Trial - a Randomized Controlled Trial of an Educational Intervention for Untreated Chronic Obstructive Pulmonary Disease (COPD) and/or Cardiovascular Disease (CVD) Identified During Lung Cancer Screening
Lead sponsor
Nicole Ezer, MD, FRCPC, MPH
Phase
Not applicable
Overall status
Active, not recruiting
Start date
April 23, 2023
Completion date
September 30, 2027
Enrollment
330 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

copd, coronary artery calcification